Literature DB >> 21045958

A Hypomorphic Allele in the FGF8 Gene Contributes to Holoprosencephaly and Is Allelic to Gonadotropin-Releasing Hormone Deficiency in Humans.

R F Arauz1, B D Solomon, D E Pineda-Alvarez, A L Gropman, J A Parsons, E Roessler, M Muenke.   

Abstract

Holoprosencephaly (HPE), the most common malformation of the human forebrain, may arise due to interacting genetic and environmental factors. To date, at least 12 contributory genes have been identified. Fibroblast growth factor 8 (Fgf8) belongs to the FGF family of genes expressed in several developmental signaling centers, including the anterior neural ridge, which is implicated in midline anomalies in mice. In humans, FGF8 mutations have been previously reported in facial clefting and in hypogonadotropic hypogonadism, but have not been reported in patients with HPE. We screened 360 probands with HPE for sequence variations in FGF8 using High Resolution DNA Melting (HRM) and sequenced all identified variations. Here we describe a total of 8 sequence variations in HPE patients, including a putative loss-of-function mutation in 3 members of a family with variable forms of classic HPE, and relate these findings to the phenotypes seen in other conditions.

Entities:  

Year:  2010        PMID: 21045958      PMCID: PMC2941840          DOI: 10.1159/000302285

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  45 in total

Review 1.  Mechanisms of ventral patterning in the vertebrate nervous system.

Authors:  Giuseppe Lupo; William A Harris; Katharine E Lewis
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 2.  Genes and signaling events that establish regional patterning of the mammalian forebrain.

Authors:  Renée V Hoch; John L R Rubenstein; Sam Pleasure
Journal:  Semin Cell Dev Biol       Date:  2009-03-03       Impact factor: 7.727

3.  Genomic structure, sequence, and mapping of human FGF8 with no evidence for its role in craniosynostosis/limb defect syndromes.

Authors:  K Yoshiura; N J Leysens; J Chang; D Ward; J C Murray; M Muenke
Journal:  Am J Med Genet       Date:  1997-10-31

4.  Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Richard Quinton; Simon Pearce; Taneli Raivio; James Acierno; Andrew Dwyer; Lacey Plummer; Virginia Hughes; Stephanie Seminara; Yu-Zhu Cheng; Wei-Ping Li; Gavin Maccoll; Anna V Eliseenkova; Shaun K Olsen; Omar A Ibrahimi; Frances J Hayes; Paul Boepple; Janet E Hall; Pierre Bouloux; Moosa Mohammadi; William Crowley
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

Review 5.  Molecular pathology of the fibroblast growth factor family.

Authors:  Pavel Krejci; Jirina Prochazkova; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

6.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

Authors:  John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

7.  Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo.

Authors:  Y Maruoka; N Ohbayashi; M Hoshikawa; N Itoh; B L Hogan; Y Furuta
Journal:  Mech Dev       Date:  1998-06       Impact factor: 1.882

8.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

9.  Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1.

Authors:  J Galceran; E M Miyashita-Lin; E Devaney; J L Rubenstein; R Grosschedl
Journal:  Development       Date:  2000-02       Impact factor: 6.868

Review 10.  Longitudinal organization of the anterior neural plate and neural tube.

Authors:  K Shimamura; D J Hartigan; S Martinez; L Puelles; J L Rubenstein
Journal:  Development       Date:  1995-12       Impact factor: 6.868

View more
  26 in total

1.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

2.  Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly.

Authors:  Emily F Kauvar; Ping Hu; Daniel E Pineda-Alvarez; Benjamin D Solomon; Amalia Dutra; Evgenia Pak; Brooke Blessing; Virginia Proud; Alan L Shanske; Cathy A Stevens; Jill A Rosenfeld; Lisa G Shaffer; Erich Roessler; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2010-12-21       Impact factor: 4.797

3.  Loss-of-function mutations in FGF8 can be independent risk factors for holoprosencephaly.

Authors:  Sungkook Hong; Ping Hu; Erich Roessler; Tommy Hu; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 4.  Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction.

Authors:  Hichem Miraoui; Andrew Dwyer; Nelly Pitteloud
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 5.  Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans.

Authors:  Anna Petryk; Daniel Graf; Ralph Marcucio
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-10-22       Impact factor: 5.814

6.  NOTCH, a new signaling pathway implicated in holoprosencephaly.

Authors:  Valérie Dupé; Lucie Rochard; Sandra Mercier; Yann Le Pétillon; Isabelle Gicquel; Claude Bendavid; Georges Bourrouillou; Usha Kini; Christel Thauvin-Robinet; Timothy P Bohan; Sylvie Odent; Christèle Dubourg; Véronique David
Journal:  Hum Mol Genet       Date:  2010-12-31       Impact factor: 6.150

Review 7.  Holoprosencephaly: recommendations for diagnosis and management.

Authors:  Emily F Kauvar; Maximilian Muenke
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

8.  A broad range of ophthalmologic anomalies is part of the holoprosencephaly spectrum.

Authors:  Daniel E Pineda-Alvarez; Benjamin D Solomon; Erich Roessler; Joan Z Balog; Donald W Hadley; Wadih M Zein; Casey K Hadsall; Brian P Brooks; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2011-10-04       Impact factor: 2.802

Review 9.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

10.  Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome.

Authors:  Sungkook Hong; Ping Hu; Juliana Marino; Sophia B Hufnagel; Robert J Hopkin; Alma Toromanović; Antonio Richieri-Costa; Lucilene A Ribeiro-Bicudo; Paul Kruszka; Erich Roessler; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.